09:34 Apr 30

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
891.65
+11.85 (+1.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
891.65
+11.85 (+1.35%)
09:34 Apr 30
Quality
image/svg+xml

95/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

7

Weakness

0

Opportunity

1

Threats

0

12.78 %

ROE %

9.55 %

ROA %

30.77

EPS

245.14

BVPS

9.88 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
5393.13 5305.79 5652.62 6228.62 6419.43
Operating Expenses +
3835.58 4431.63 4944.24 5295.27 5423.05
Raw Material
1451.27 1489.61 1630.17 1857.92 2012.22
Increase Decrease in Cost
-193.93 -43.19 78.65 -142.84 -370.1
Other Manufacturing Expense
22.39 0 50.9 0 0
Employee Cost
1051.17 1133 1169.13 1446.29 1570.61
Miscellaneous Expenses
2036.52 2573.21 2775.57 3043.72 2210.32
Operating Profit
1557.55 874.16 708.38 933.35 996.38
Other Income
10.02 50.46 2.74 28.31 31.94
Depreciation
183.47 286.78 275.43 272.67 279.07
Interest
16.02 17.73 50.17 56.19 65.19
Profit before tax and exceptio..
1368.08 620.11 385.52 632.8 684.06
Exceptional Items
0 0 0 0 12.87
PBT
1368.08 620.11 385.52 632.8 671.19
Provision for Taxation
253.32 104.46 12.61 16 94.49
Net Profit
1114.76 515.65 372.91 616.8 602.44
NET Profit after MI
1178.11 520.94 341.99 615.82 604.74
EPS
60.81 26.5 17.4 31.33 30.72
Operating Profit Margin (%)
28.88 16.48 12.53 14.98 15.52
Net Profit Margin (%)
21.84 9.82 6.05 9.89 9.42

ShareHolding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 69.70 69.60 69.60 69.60 69.60
FII 3.90 4.20 3.90 4.30 4.50
MF 9.20 9.00 8.90 8.00 7.80
Public 10.00 10.20 10.40 10.60 10.50
Others 0.00 0.00 0.00 0.00 0.10
Others 7.20 7.00 7.20 7.50 7.50
Shareholder Shares Holding %

Download Our App On: